A UK start-up, CN Creative Ltd, which has developed an electronic smoking cessation device, has raised £2 million in a Series A round led by Advent Life Sciences. The money will support final development of its novel inhaler product. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News